about
Confounding in the association of proton pump inhibitor use with risk of community-acquired pneumoniaProton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?Acute Δ(9)-tetrahydrocannabinol blocks gastric hemorrhages induced by the nonsteroidal anti-inflammatory drug diclofenac sodium in miceAssociation of long-term proton pump inhibitor therapy with bone fractures and effects on absorption of calcium, vitamin B12, iron, and magnesiumInhibition of monoacylglycerol lipase attenuates nonsteroidal anti-inflammatory drug-induced gastric hemorrhages in mice.Divergent trends for gastric cancer incidence by anatomical subsite in US adults.Current trends in the management of gastroesophageal reflux disease: a review.Use of Proton-Pump Inhibitors Predicts Heart Failure and Death in Patients with Coronary Artery Disease.A patient on long-term proton pump inhibitors develops sudden seizures and encephalopathy: an unusual presentation of hypomagnesaemia.Gastric acid suppression and outcomes in Clostridium difficile infection: a population-based study.Electrical stimulation therapy of the lower esophageal sphincter is successful in treating GERD: final results of open-label prospective trialAssociation Between the Use of Proton Pump Inhibitors and the Risk of ESRD in Renal Diseases: A Population-Based, Case-Control Study.Enlightening discriminative network functional modules behind Principal Component Analysis separation in differential-omic science studies.Systematic review: hypomagnesaemia induced by proton pump inhibition.MAGL inhibition modulates gastric secretion and motility following NSAID exposure in mice.Systematic review with meta-analysis: fundic gland polyps and proton pump inhibitors.A debate on the roles of antireflux surgery and long term acid suppression in the management of gastro-oesophageal reflux disease.Sympathetic Nerve Entrapment Point Injection as an Antireflux Procedure for Refractory Laryngopharyngeal Reflux: A First Case Report of Innovative Autonomic Regulation.Dose-dependent inhibitory effects of proton pump inhibitors on human osteoclastic and osteoblastic cell activity.Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse.Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trialÉpidémiologie et facteurs pronostiques des hémorragies digestives hautes en Côte d’ivoire : étude prospective observationnelle multicentrique
P2860
Q28396345-98E73313-CDBA-4A90-8BB3-03E0310F1245Q30620638-7D692610-9205-4785-8EA5-008EE5684843Q33739530-BA904526-501D-4EE9-8A1B-9DE450A50BC9Q34140914-CE7130BF-29F7-4C99-BB91-C37B8A45B321Q35188129-6CB32332-9674-4CCB-983C-9961F14DD6FDQ35449763-395B4969-CC87-44B1-9B3F-38DF48965AE0Q36107247-6FDF9142-D1D2-4563-82FB-8FB100A244D6Q36254177-23867E3E-3C96-4963-83C4-7F757F87F711Q36424604-AB0623E7-62EE-41B5-B298-091759324EDAQ36513062-346CC2C9-DEDC-4D4E-9DD5-703C4F31E96DQ36689097-B879AA29-3F89-4B64-9357-81911A7EDD17Q36822474-7F45B6D1-1B5C-4333-A569-09C7CA8E5A25Q37695361-820DD434-B4D1-4EF7-9C16-34FA6CD94ECFQ38023882-921B9DCF-0CB7-490F-9A1D-CF81C7B8A913Q38800501-A25F8894-F1E4-485D-BF80-42A5534ACD7DQ38955844-4FEE5C8B-9583-490B-A8EE-A4A73258BBF1Q41060363-004B1276-C310-491A-BB7E-3D15C33283A2Q42322668-BDC1BC12-0DA8-406C-9CB3-C7787C0062C2Q45773103-C7CDE3B1-06ED-4477-A80D-086F311EA515Q48198180-7A3793AD-6B32-44C2-8718-47822524FD16Q58003581-15CA8933-1F47-4BE3-8A1B-77A820150252Q58209089-0C90E48B-EF8F-47F2-9518-D81878F26454
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on April 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Adverse effects of proton pump inhibitors.
@en
Adverse effects of proton pump inhibitors.
@nl
type
label
Adverse effects of proton pump inhibitors.
@en
Adverse effects of proton pump inhibitors.
@nl
prefLabel
Adverse effects of proton pump inhibitors.
@en
Adverse effects of proton pump inhibitors.
@nl
P2093
P1476
Adverse effects of proton pump inhibitors.
@en
P2093
Federica Buonfiglioli
Francesca Lodato
Francesco Azzaroli
Marco Zoli
Natalia Mazzella
P304
P356
10.1016/J.BPG.2009.11.004
P577
2010-04-01T00:00:00Z